-
公开(公告)号:US5550119A
公开(公告)日:1996-08-27
申请号:US403353
申请日:1995-03-02
IPC分类号: C07F9/6524 , C07F9/280
CPC分类号: C07F9/6524
摘要: The present invention relates to the N-phosphonomethyl substituted compounds of formula ##STR1##
摘要翻译: 本发明涉及式(I)的N-膦酰基甲基取代的化合物,
-
公开(公告)号:US5506242A
公开(公告)日:1996-04-09
申请号:US265296
申请日:1994-06-24
IPC分类号: A61K31/18 , A61K31/00 , A61K31/335 , A61K31/357 , A61K31/38 , A61K31/381 , A61K31/382 , A61K31/40 , A61K31/415 , A61K31/42 , A61K31/425 , A61K31/426 , A61K31/435 , A61K31/44 , A61K31/4402 , A61K31/4406 , A61K31/4409 , A61K31/4418 , A61K31/4427 , A61K31/443 , A61K31/445 , A61K31/4465 , A61K31/4468 , A61K31/47 , A61K31/535 , A61K31/5375 , A61K31/5377 , A61K31/55 , A61P1/00 , A61P1/02 , A61P1/04 , A61P19/10 , A61P27/02 , A61P29/00 , A61P31/12 , A61P35/00 , A61P37/04 , A61P43/00 , C07C311/19 , C07C311/29 , C07C311/42 , C07C323/59 , C07D207/08 , C07D207/09 , C07D207/16 , C07D211/26 , C07D211/28 , C07D211/34 , C07D211/58 , C07D211/66 , C07D211/96 , C07D213/42 , C07D213/71 , C07D215/12 , C07D223/10 , C07D231/12 , C07D231/14 , C07D233/24 , C07D233/64 , C07D233/68 , C07D233/84 , C07D257/04 , C07D261/10 , C07D277/06 , C07D277/20 , C07D277/28 , C07D277/30 , C07D277/36 , C07D295/12 , C07D295/14 , C07D307/16 , C07D309/04 , C07D309/14 , C07D313/18 , C07D317/58 , C07D317/60 , C07D317/62 , C07D333/34 , C07D333/58 , C07D335/02 , C07D401/04 , C07D401/06 , C07D401/12 , C07D405/12 , C07D413/06 , C07D413/12 , C07D521/00 , C07D403/06
CPC分类号: C07D213/42 , C07C311/19 , C07C311/29 , C07C311/42 , C07D207/09 , C07D207/16 , C07D211/26 , C07D211/34 , C07D211/58 , C07D211/66 , C07D215/12 , C07D223/10 , C07D231/12 , C07D233/24 , C07D233/56 , C07D249/08 , C07D257/04 , C07D261/10 , C07D277/06 , C07D277/28 , C07D307/16 , C07D309/14 , C07D313/18 , C07D317/58 , C07D317/62 , C07D333/58 , C07D335/02 , C07D401/04 , C07D401/12 , C07D405/12 , C07D413/12 , C07C2101/14
摘要: The invention relates to a method of inhibiting metalloellastase activity, of inhibiting the degradation of elastin, or of treating macrophage metalloelastase dependent conditions in mammals which comprises administering to a mammal in need thereof an effective macrophage metalloelastase inhibiting amount of a compound of formula I ##STR1## wherein Ar, R, R.sub.1 and R.sub.2 have meanings as defined, or of a pharmaceutically acceptable prodrug derivative thereof, or of a pharmaceutically acceptable salt thereof, or of pharmaceutical compositions comprising a said compound.
摘要翻译: 本发明涉及一种抑制金属蛋白酶活性,抑制弹性蛋白降解或治疗哺乳动物中巨噬细胞金属弹性蛋白酶依赖性条件的方法,该方法包括向有需要的哺乳动物施用有效的巨噬细胞金属弹性蛋白酶抑制量的式I化合物 (I)其中Ar,R,R 1和R 2具有如上定义的含义,或其药学上可接受的前药衍生物或其药学上可接受的盐,或包含所述化合物的药物组合物。
-